Frieder Berr, Joseph Holl, Dieter Jüngst, Sven Fischer, Werner O. Richter, Bernd Seifferth, Gustav Paumgartner – 1 October 1992 – Because fatty acid composition of biliary phospholipids influences cholesterol secretion into bile, we investigated whether replacement of n‐1 monounsaturated or n‐6 polyunsaturated fatty acids with n‐3 polyunsaturated fatty acids in biliary phosphatidylcholines reduces supersaturation with cholesterol and prevents precipitation of cholesterol crystals in bile of gallstone patients.

Mercedes Ruiz‐Moreno, Maria José Rua, Inmaculada Castillo, Maria Dolores García‐Novo, Maravillas Santos, Sonia Navas, Vicente Carreño – 1 October 1992 – Twelve children with chronic non‐A, non‐B hepatitis were entered in a pilot trial of recombinant interferon‐α. Although all the children had hepatitis C virus RNA in serum, only five had antibodies against this virus. Children received 3 MU/m2 body surface area interferon‐α 3 times/wk for 6 mo; they were followed for 24 mo, including the therapy period.

Michael W. Fried, Julia C. Korenman, Adrian M. Di Bisceglie, Yoon Park, Jeanne G. Waggoner, Hiroaki Mitsuya, Neil R. Hartman, Robert Yarchoan, Samuel Broder, Jay H. Hoofnagle – 1 October 1992 – The nucleoside analog 2′,3′‐dideoxyinosine, currently being used to treat patients infected with the human immunodeficiency virus, has been shown to inhibit viral replication in certain cell culture systems of hepatitis B virus and the duck model of chronic hepatitis B infection. We studied the effect of dideoxyinosine on viral replication in patients with chronic hepatitis B.

Chris J. Dickinson – 1 October 1992 – An outbreak of hepatitis A virus (HAV) infection in a neonatal intensive care unit (NICU) provided the opportunity to examine the duration of HAV excretion in infants and the mechanisms by which HAV epidemics are propagated in NICUs. The outbreak affected 13 NICU infants (20%), 22 NICU nurses (24%), 8 other staff caring for NICU infants, and 4 household contacts; 2 seropositive infants (primary cases) received blood transfusions from a donor with HAV infection.

Wei‐Li Hu, Paul A. Chindemi, Erwin Regoeczi – 1 October 1992 – The single oligosaccharide attachment in rat transferrin exhibits marked structural microheterogeneity. In this study we examined whether all microheterogeneous forms of rat transferrin found in plasma are derived from a single organ, such as the liver. To this end we analyzed the glycans of rat transferrin synthesized by the isolated perfused rat liver by a method established earlier for rat transferrin isolated from rat plasma.

Clara Mandell, Lucia Cesarini, Alberto Piperno, Silvia Fargion, Anna L. Fracanzani, Donatella Barisani, Dario Conte – 1 October 1992 – The relationship of pretreatment serum ferritin and hepatic iron concentration to body iron removed by venesections was evaluated in 33 patients with genetic hemochromatosis. The median values of the three variables considered were 1,950 μg/L (range = 255 to 10,000), 1,175 μg/100 mg dry weight (range = 270 to 4,310) and 10 gm (range = 2 to 41), respectively.

Robert H. Resnick – 1 October 1992

Keith S. Henley, Daniel P. Normolle – 1 October 1992

Nisen Abuaf, Catherine Johanet, Pascale Chretien, Eric Martini, Emmanuelle Soulier, Syria Laperche, Jean Claude Homberg – 1 October 1992 – An autoantibody to liver cytosol was previously described in childhood autoimmune chronic active hepatitis type 2. The antigen, liver cytosol antigen type 1, was for the first time partially purified using gel filtration and ion exchange chromatography, and it was characterized using immunodiffusion, immunoblot and sodium dodecyl sulfate—polyacrylamide gel electrophoresis analysis of the immunoprecipitate.

1 October 1992